Liraglutide in Spinal Fluid (LIRA-CSV)

Mikkel Christensen

Status: Completed

Conditions: Liraglutide Blood-brain Transfer

Treatments: Procedure: Lumbar puncture

Study type: Interventional

Funder types: Other

Identifiers

NCT02104037

H-2-2011-027

Details and patient eligibility

About

The purpose of this study is to investigate transfer of liraglutide from blood to cerebrospinal fluid.

Enrollment: 8 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Type 2 diabetes treated with liraglutide 1.8 mg for 1 month and 5% weight loss

Exclusion criteria

Trial design

Primary purpose: Basic Science

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

Liraglutide treated patients

Experimental group

Treatment:

Procedure: Lumbar puncture